Dr Liliya Kopanitsa

Advanced Research Assistant

I joined Translational Cancer Genomics in March 2022 to work in the Human Genetic Interaction project. In my previous post, I studied the sensitivity of glioblastoma cells to natural and synthetic compounds and their combinations at IOTA Pharmaceuticals, a Cambridge-based biotech company.

My timeline